Daphne Quimi
CIK 1543031 · Chief Financial Officer · last filed 2026-06-08
Daphne Quimi is a Chief Financial Officer who has filed 59 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing, for AMLX, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $51.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$51.4K
3
59
-$1.58M
Holdings By Company
Recent Filings
59 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | AMLX | Grant (A) | — | $0 | EDGAR |
| 2025-06-16 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | AMLX | Grant (A) | — | $0 | EDGAR |
| 2024-09-16 | IPSC | Buy (P) | +5,000 | $7.7K | EDGAR |
| 2024-06-21 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | AMLX | Grant (A) | — | $0 | EDGAR |
| 2024-05-16 | AMLX | Buy (P) | +5,000 | $9.4K | EDGAR |
| 2023-06-29 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | AMLX | Grant (A) | — | $0 | EDGAR |
| 2023-01-19 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −11,923 | -$152.4K | EDGAR |